GenoMethods - Biotechnology, Bioinformatics & AI in Biology

Living drugs upend cancer treatment at Tang Prize Masters Forum

At the Tang Prize Masters Forum, Steven Rosenberg, Michel Sadelain, and Carl June showed how engineered immune cells and AI are changing cancer care and autoimmune disease treatment.

By Elena MacLeod · September 26, 2026, 7:14 AM · 6 mins read

Clinical Trials & Evidence

Kyverna Therapeutics shows one-year drug-free remission with miv-cel in tough neurologic autoimmune diseases

By Elena MacLeod

Genomics & Multiomics

NIH single cell brain atlas rewrites Alzheimer’s molecular map

By Adrian Cole

Clinical Trials & Evidence

Artiva Biotherapeutics to present new AlloNK trial results in Paris

By Elena MacLeod

Biotechnology News & Analysis

How a random positioning machine lets scientists mimic microgravity for human cells

By Adrian Cole

IN-DEPTH REPORTING

Genomics & Multiomics

Brain atlas growth stalls clinical progress without real-world testing

A new editorial says bigger brain atlases alone won't lead to better treatments unless researchers test function and set clear data standards.

By Adrian Cole · September 25, 2026, 5:44 PM

Genome Editing

Gene editing changes the game for crop breeding

September 25, 2026, 3:42 PM

Clinical Trials & Evidence

Cilta-cel moves up in multiple myeloma as CAR T first strategy gains ground

September 25, 2026, 1:45 PM

BIOTECHNOLOGY NEWS & ANALYSIS >

Drug Discovery

VERAXA Biotech pushes ahead with BiTAC cancer platform after NASDAQ listing

VERAXA Biotech has joined the NASDAQ and is moving fast on its oncology pipeline built around the BiTAC platform. The Swiss company is entering a new phase.

By Vivian Lin · September 24, 2026, 8:46 AM

Biotechnology News & Analysis

GC Biopharma pushes ahead with homegrown mRNA COVID-19 vaccine using full-cycle AI

September 23, 2026, 9:51 PM

Drug Discovery

Sai Life Sciences gets CRISPR Cas9 license for global drug discovery work

September 23, 2026, 5:13 PM

CLINICAL TRIALS & EVIDENCE >

Clinical Trials & Evidence

Marker Therapeutics locks in expanded US cell therapy manufacturing for MT-601

Marker Therapeutics gets a major lift for its lead cell therapy MT-601 as Kincellis Advanced Therapies steps in with bigger US manufacturing and deeper technical know-how.

By Elena MacLeod · September 23, 2026, 2:37 PM

Biotech Companies & Pipelines

Arvaya Healthcare sets up insurance arm, eyes rights issue for expansion

September 23, 2026, 12:43 PM

Clinical Trials & Evidence

New clinical trial data and risk warnings shake up blood cancer care at SOHO 2026

September 22, 2026, 7:57 PM

Biotechnology, Decoded

GenoMethods explains biotechnology from method to medicine to market, connecting scientific evidence, clinical development, companies and the technologies shaping future health.

TOP STORIES

Living drugs upend cancer treatment at Tang Prize Masters Forum

Kyverna Therapeutics shows one-year drug-free remission with miv-cel in tough neurologic autoimmune diseases

NIH single cell brain atlas rewrites Alzheimer’s molecular map

Artiva Biotherapeutics to present new AlloNK trial results in Paris

How a random positioning machine lets scientists mimic microgravity for human cells

IN-DEPTH REPORTING

Brain atlas growth stalls clinical progress without real-world testing

Gene editing changes the game for crop breeding

Cilta-cel moves up in multiple myeloma as CAR T first strategy gains ground

FEATURED STORIES

Blood DNA methylation patterns flag cancer risk years before diagnosis

Fusion CX takes full control of VA Platinum Offshoring in strategic acquisition

Anixa wins Australian patent for breast cancer vaccine technology through 2040

Zymeworks completes Theravance Biopharma buyout, adds new assets and revenue streams

Dark genome mutations spark different inflammation routes in aging blood cells

New myasthenia gravis trial results set to reshape neuromuscular medicine at AANEM 2026

BIOTECHNOLOGY NEWS & ANALYSIS >

VERAXA Biotech pushes ahead with BiTAC cancer platform after NASDAQ listing

GC Biopharma pushes ahead with homegrown mRNA COVID-19 vaccine using full-cycle AI

Sai Life Sciences gets CRISPR Cas9 license for global drug discovery work

CLINICAL TRIALS & EVIDENCE >

Marker Therapeutics locks in expanded US cell therapy manufacturing for MT-601

Arvaya Healthcare sets up insurance arm, eyes rights issue for expansion

New clinical trial data and risk warnings shake up blood cancer care at SOHO 2026

Biotechnology, Decoded